Angelini Ventures strengthens Leadership Team with appointment of renowned BioTech Investor Dr. Regina Hodits 4/7/2025 Category: TALENT
Angelini Ventures leads €10M investment in Vantis to digitally revolutionize chronic disease management 3/12/2025 Category: INVESTMENTS
Nobi's smart light technology secures €35M Series B funding, co-led by Angelini Ventures 1/28/2025 Category: INVESTMENTS
Angelini Ventures co-leads €20M Series A in Neumirna to pioneer RNA therapies for neurological diseases 1/9/2025 Category: INVESTMENTS
Damona Pharmaceuticals receives FDA clearance to initiate Phase 1 clinical trial for innovative brain disorder treatment 11/6/2024 Category: PORTFOLIO NEWS
Angelini Ventures contributes to the new Angelini Industries ESG Strategy 2024-2026 11/6/2024 Category: SUSTAINABILITY
Angelini Ventures